Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)
Breast Cancer · 2025
DOI: 10.1007/s12282-025-01700-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Breast Cancer, 2025. Verfasst von Rurina Watanuki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eli Lilly Japan.
Abstract (Originalsprache)
Background
Patients with early recurrence of hormone receptor (HR)-positive, HER2-negative (HR+/HER2−) breast cancer have a poor prognosis. We aimed to identify clinical and pathological risk factors for recurrence within three years after surgery of HR+/HER2− breast cancer.
Methods
We retrospectively reviewed clinical data of patients with stage II–III HR+/HER2− breast cancer who received adjuvant endocrine therapy from January 1, 2012 to January 1, 2017 at five institutions. Using univariable and multivariable analyses, we determined risk factors for invasive disease-free survival (IDFS). A nomogram was generated using variables from the multivariable analysis to predict 3-year IDFS rate.
Results
A total of 2732 patients were analyzed, with a median follow-up of 7.1 years. The 3-year IDFS rate was 92.1%. Multivariable analysis for IDFS revealed significant risk factors: age (40–69 vs. 20–39 years: HR 0.69, p = 0.011), nuclear grade (Grade 2 vs. Grade 1: HR 1.66, p < 0.001; Grade 3 vs. Grade 1: HR 1.64, p < 0.001), vascular invasion (Yes vs. No: HR 1.36, p = 0.027), pathological invasive tumor size (2–5 cm vs. < 2 cm: HR 1.75, p < 0.001; ≥ 5 cm vs. < 2 cm: HR 2.07, p < 0.001), number of positive lymph nodes (≥ 4 vs.0: HR 1.70, p < 0.001), and neoadjuvant chemotherapy (NAC) (Yes vs. No: HR 2.41, p < 0.001). The nomogram’s concordance index was 0.68.
Conclusion
Younger age, nuclear grade, vascular invasion, tumor size and number of lymph node metastases were identified as independent risk factors for early recurrence. Patients whose physicians chose NAC had worse survival than those who did not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan.
- Advanced Cancer Translational Research Institute, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku,, Tokyo, 142-8555, Japan. sakai-h@med.showa-u.ac.jp.
- Department of Breast Surgical Oncology, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo, 104-8560, Japan.
- Division of Breast Surgical Oncology, Department of Surgery, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
- Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
- Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Förderung
- Eli Lilly Japan
Zitieren
APA
Watanuki, R., Sakai, H., Takehara, Y., Yoshida, A., Hayashi, N., Ozaki, Y., Kataoka, A., Uehiro, N., Kamio, H., Onishi, M., Fushimi, A., Ikeno, T., Wakabayashi, M., Iida, M., Kawaguchi, T., & Takano, T. (2025). Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B). Breast Cancer. https://doi.org/10.1007/s12282-025-01700-y
Vancouver
Watanuki R, Sakai H, Takehara Y, Yoshida A, Hayashi N, Ozaki Y, et al. Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B). Breast Cancer. 2025. doi:10.1007/s12282-025-01700-y
BibTeX
@article{Watanuki2025,
author = {Watanuki, Rurina and Sakai, Hitomi and Takehara, Yuri and Yoshida, Atsushi and Hayashi, Naoki and Ozaki, Yukinori and Kataoka, Akemi and Uehiro, Natsue and Kamio, Hidenori and Onishi, Mai and Fushimi, Atsushi and Ikeno, Takashi and Wakabayashi, Masashi and Iida, Mayumi and Kawaguchi, Tsutomu and Takano, Toshimi},
title = {Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)},
journal = {Breast Cancer},
year = {2025},
doi = {10.1007/s12282-025-01700-y}
}
EUVIMED